In a new article from the Wall Street Journal, “Novartis AG said its head of pharmaceuticals, David Epstein, is to leave the company amid a restructuring that will split his role in two.” For more information on this transition, please visit: http://www.wsj.com/articles/novartis-to-split-pharmaceuticals-division-into-two-1463506092